Skip to content

Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Thyroidectomy

Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Thyroidectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05626010
Enrollment
62
Registered
2022-11-23
Start date
2022-11-23
Completion date
2023-11-30
Last updated
2022-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Disease

Brief summary

Acetaminophen and ibuprofen has been safely used for a long time and reduces postoperative pain and opioid dosages. Investigators are planning to compare the efficacy of 1) acetaminophen only and 2) acetaminophen and ibuprofen combination at postoperative pain after thyroidectomy.

Detailed description

Acetaminophen and ibuprofen has been safely used for a long time and reduces postoperative pain and opioid dosages. Investigators are planning to compare the efficacy of 1) acetaminophen 1g only and 2) the combination of acetaminophen 1g and ibuprofen 300mg at postoperative pain after thyroidectomy. Some recovery valuables such as the postoperative pain and opioid requirements will be assessed

Interventions

DRUGAcetaminophen

acetaminophen 1g iv dripping at end of surgery

DRUGIbuprofen

ibuprofen 300mg iv dripping at end of surgery

Sponsors

The Catholic University of Korea
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* the patients undergoing scheduled thyroidectomy * American Society of Anesthesiologists status 1 or 2

Exclusion criteria

* refusal to be enrolled in the study * emergency surgery * hepatic or renal disease * on chronic pain medications * psychiatric disorders * pregnancy, lactation * allergy or contraindication to the study drug

Design outcomes

Primary

MeasureTime frameDescription
postoperative painduring 30 minutes after surgerythe maximal postoperative pain severity using pain scale(visual analogue scale; 0 cm=no pain; 10 cm=the worst pain)

Secondary

MeasureTime frameDescription
pain killer requirementduring 30 minutes after surgerythe incidence of the patients who require pain killer

Countries

South Korea

Contacts

Primary Contactyoungeun moon, MD, PhD
0910momo@naver.com822-2258-6163
Backup Contactjaesik park, MD
cmcanepm@catholic.ac.kr822-2258-6163

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026